Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05412992 · ClinicalTrials.gov registry record · Phase 2

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

A Phase 2 study, sponsored by Teikoku Pharma USA.

Terminated
Registry status
Phase 2
Development phase
179
Enrollment target

NCT05412992: Clinical Trial Phase 2 study, sponsored by Teikoku Pharma USA.

NCT05412992 is a Phase 2 study that was terminated before completion, run by Teikoku Pharma USA. The registered enrollment target is 179 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05412992, a Phase 2 study, was terminated before completion, sponsored by Teikoku Pharma USA.

TERMINATED
Registry status
Phase 2
Development phase
179 participants
Enrollment target

Study Summary

The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

Primary Outcome

The SPI measured using the 11-point (0 to 10) numeric rating scale, where 0 is equal to no pain and 10 is equal to worst pain

Interventions

  • DRUG Placebo Patch
  • DRUG DMTS Patch

Trial Details

FieldValue
Enrollment Target 179 participants
Start Date 2022-07-07
Est. Completion 2023-04-19
Phase Phase 2
Teikoku Pharma USA

5 total trials

Why NCT05412992 stopped before completion

NCT05412992 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher).

The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.

NCT05412992 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05412992 about?

NCT05412992 is a clinical study titled "Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty". The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

What is the current status of trial NCT05412992?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 179 participants. The study started on 2022-07-07. Estimated completion is 2023-04-19.

What interventions are being tested in trial NCT05412992?

The interventions under investigation include: Placebo Patch (DRUG), DMTS Patch (DRUG).

Who is sponsoring clinical trial NCT05412992?

This trial is sponsored by Teikoku Pharma USA, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05412992's enrollment target sits among peer trials

179 391st of 2000 higher than 1,610 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06581198 · 179 participants · Phase 2

    A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

  • NCT07356323 · 179 participants · NA

    A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05412992, the US trial registry maintained by the National Library of Medicine. NCT05412992 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.